To assess changes in asthma exacerbation rate in patients receiving benralizumab in the real world.Methods: XALOC-1 is an international (Canada, Italy, Spain, and UK) retrospective study of benralizumab effectiveness in adults with severe eosinophilic asthma (SEA) comprising patients with 鈮 12...
Additional large-cohort data are needed to confirm its real-world effectiveness in SEA according to previous biologic use and key baseline characteristics important for treatment selection.Methods XALOC-1 is a large, multinational, retrospective, observational, real-world study programme of benralizumab...